Adamax
Synthetic peptide · proprietary research preparation
Identifier graph
Cross-references to canonical chemistry knowledge graphs. Each binding is the same identity used in PubMed-indexed literature.
What is Adamax?
Adamax is a research-grade peptide preparation supplied by NMChem for laboratory characterisation. The public literature on this compound is limited; researchers should consult the per-batch Certificate of Analysis for compositional details and contact NMChem directly for synthesis information not in the public record.
Mechanism of action
Limited public mechanistic data are available. Adamax is supplied for laboratory characterisation work where the primary research question is the compound's biological activity profile rather than confirmation of an established mechanism.
Research context
Limited published research context. Researchers investigating Adamax are encouraged to contribute their findings to the open literature.
Analytical specifications
Every batch of Adamax supplied by NMChem is characterised by reversed-phase HPLC for purity determination and by mass spectrometry for identity confirmation. Certificate of Analysis (COA) documents are issued per batch and made available on request.
Identity is confirmed by electrospray-ionisation mass spectrometry (ESI-MS); the observed mass falls within ±2 Da of the theoretical monoisotopic mass calculated from the residue sequence. Purity is determined by reversed-phase HPLC on a C18 column with a trifluoroacetic-acid-modified water/acetonitrile gradient and reported as the area-under-curve percentage of the main peak at 214 nm. NMChem specification is ≥99% main peak. Material ships as lyophilised powder and must be reconstituted in sterile water or bacteriostatic water immediately before use.
UK regulatory status
Supplied as a research-grade reference standard for laboratory use only. Not a licensed medicinal product in the United Kingdom and not approved by the MHRA for human or veterinary administration. Sale is restricted to researchers, institutions and laboratory professionals; the compound must be retained within research premises. End-user compliance with the Human Medicines Regulations 2012, the Misuse of Drugs Act 1971 (where applicable) and local institutional biosafety policy is the responsibility of the buyer.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound.
-
Enhancing accuracy in brain stroke detection: Multi-layer perceptron with Adadelta, RMSProp and AdaMax optimizers.
Uppal M et al. · Frontiers in bioengineering and biotechnology · 2023
PubMed PMID 37823024 -
Mine Gas Concentration Forecasting Model Based on an Optimized BiGRU Network.
Liang R et al. · ACS omega · 2020
PubMed PMID 33195909 -
Effective skin cancer classification by modified and optimized inception-ResNet-V2 model.
Umapathi K et al. · Scientific reports · 2025
PubMed PMID 41266780
Related compounds
Other research compounds in adjacent mechanism classes or commonly used alongside Adamax.
Frequently asked questions about Adamax
What can you tell me about Adamax?
Get research-grade Adamax from NMChem
UK supplier · HPLC and MS verified · Per-batch Certificate of Analysis · Tracked Royal Mail dispatch.